Summary The in vivo and in vitro effects of human a-interferon (IFN) on blood natural killer (NK) cell activity were studied in patients with malignant melanoma. The initial response to an i.m. injection of IFN was a depression of blood NK cell activity, being detectable at 4h and reaching a nadir at 12h. Blood NK cell activity returned to or exceeded pretreatment levels within 24 h. 
There is increasing evidence that natural killer (NK) cells play an important role in host defence mechanisms against tumours, microbes, and virusinfected cells (Herberman, 1980 (Herberman, , 1982 , although the actual biological significance of NK cells is not yet understood. We have recently demonstrated that a minor proportion of blood and tumour-associated NK cells kill autologous tumour cells freshly isolated from the same cancer patients (Uchida & Micksche, 1983a) . Recent reports have indicated that human NK cells activity is strongly associated with a morphological subpopulation of lymphoid cells, termed large granular lymphocytes (LGL) (Timonen et al., 1981) . Although LGL are not synonymous with NK cells, more than 50% of
LGL have been shown to function as active NK cells by using a single cell level assay . The activity of NK cells appears to be highly regulated in both positive and negative ways (Herberman, 1980 (Herberman, , 1982 : Interferon (IFN) plays a central role in the augmentation of NK cell activity (Gidlund et al., 1978; Trinchieri et al., 1978; Herberman et al., 1979) , whereas suppressor cells inhibit NK cell activity (Uchida & Micksche, 1981a , 1983b Uchida et al., 1982 Uchida et al., , 1984 Boldignon et al., 1982) . IFN has been demonstrated to enhance NK cell activity through recruitment of pre-NK cells that have pre-existing ability to bind NK-susceptible target cells but cannot kill these target cells and through activation of both pre-NK cells and active NK cells (Saksela et al., 1979; Targan & Dorey, 1980) . We have previously reported that the streptococcal preparation OK432 augments NK cell activity by activating LGL with pre-existing capacity to recognize cells independently of IFN induction (Uchida & Micksche, 1981b , 1983b . On the other hand, adherent types of suppressor cells from malignant pleural effusions of cancer patients and from the peripheral blood of postoperative cancer patients have been reported to suppress the maintenance of functional NK cells and the development of active NK cells through IFN (Uchida & Micksche, 1981a , 1983b Uchida et al., 1982 Uchida et al., , 1984 .
Considerable attention has recently been paid to the use of IFN as a new therapeutic approach for human cancer (Gutterman et al., 1980; Priestman, 1980) . Since IFN is known to be an important modulator of NK cell activity (Gidlund et al., 1978; Trinchieri et al., 1978; Herberman et al., 1979) , several studies have focused on the changes in blood NK cell activity of cancer patients undergoing IFN treatment. Systemic administration of IFN has been demonstrated to result in an increase in blood NK cell activity (Huddlestone et al., 1979; Einhorn et al., 1980 Einhorn et al., , 1983 Golub et al., 1982a Golub et al., , 1982b Lotzova et al., 1982 Lotzova et al., , 1983 ). An initial decline in blood NK cell activity has also been documented in patients with chronic hepatitis (Pape et al., 1981) , in cancer patients (Koren et al., 1983; Golub et al., 1982a Golub et al., , 1982b , and in normal donors (Karimiemi et al., 1980) Cell preparation Lymphocyte-rich mononuclear cells were isolated from heparinized peripheral blood by centrifugation on Ficoll-Hypaque gradients and further fractionated as described previously (Uchida & Micksche, 1981a , 1981b , 1983a , 1983b , 1983c . Mononuclear cells collected from the interface were washed and suspended in RPMI 1640 medium supplemented with 2mM L-glutamine, 25 mM HEPES, 100 U penicillin ml-', 100 ug streptomycin ml-', and 10% heat-inactivated foetal calf serum (FCS) (Gibco Bio-Cult, Glasgow, Scotland) (complete medium). The mononuclear cells were then incubated for 1 h at 37°C in plastic dishes that had been precoated with FCS. After incubation, nonadherent cells were removed, and the dish was washed with cold medium. Adherent cells were harvested from the dish after 15 min incubation with Versene (1/5000, Gibco Bio-Cult) and by vigorous washing with a pipette, then washed and suspended in complete medium. The adherent cells contained > 94% monocytes as judged by morphologic examination and nonspecific esterase staining. The nonadherent cells were further incubated on nylon-wool columns for 1 h at 37°C, and then eluted with warm medium. The nylonwool nonadherent cells contained >98% lymphocytes as judged by morphologic examination of Giemsa-stained smears. Every fraction was >97% viable by dye exclusion. Effector cells were used either immediately or stored at 4°C at a concentration of 106 ml-' in complete medium, since under the condition there were no differences in cytotoxicity of fresh and cultured cells (Uchida & Micksche, 1981a ). 51Cr release cytotoxicity assay A 4h 51Cr release assay was performed using the K562 human erythromyeloid leukemia cell line (Lozzio & Lozzio, 1975) as targets, as detailed elsewhere (Uchida & Micksche, 1981a , 1981b , 1983a , 1983b , 1983c . Briefly, 100,l 51Cr-labelled target cells (5 x 103) and 100l 1 effector cells in different numbers were added to each well of round-bottomed microtiter plates. After 4 h incubation, the supernatant was collected, and the specific 5 Cr release in percentage cytotoxicity was calculated by the formula for triplicate samples: % Cytotoxicity = (test cpm-spontaneous cpm)/(maximum cpm -spontaneous cpm) x 100.
Lytic units (LU) were calculated from doseresponse curves obtained by different numbers of effector cells by using linear regression analysis, as described previously (Uchida & Micksche, 1983b) . One LU was defined as the number of effector cells required to induce 20% lysis of target cells, and the results are expressed as the number of LU/106 cells.
Agarose single cell cytotoxicity assay This assay was performed as described previously (Uchida & Micksche, 1983a; Uchida et al., 1984) . Equal numbers (2 x 105) of nylon-wool nonadherent lymphocytes and K562 were mixed in 0.2 ml medium, incubated for 10 min at 37°C, and centrifuged at 100 g for 5 min, followed by gentle suspension with a pipette. One (Uchida & Micksche, 1981b , 1983b , 1983c . After incubation, the cells were washed and suspended in complete medium.
NK suppressor assay
Effector cells (106ml-') in complete medium were precultured overnight alone or with half the number of cells used as suppressors either in the presence or absence of IFN (1,000 IUml-), as described previously (Uchida & Micksche, 1981a , 1983b Figure  1 . The initial decline in blood NK cell activity at 12h points of IFN treatment was documented in 10/12 (83.3%) patients. Twenty-four hours after IFN injection blood NK cell activity returned to base line levels in 2 patients and exceeded pretreatment levels in another 8 patients. Thus, these patients were considered as responders. The other 2 patients, however, showed no depression nor increase in (Table II) . There was no difference in the (Ortaldo & Herberman, 1980; Targan & Dorey, 1980) and since the post-binding lytic activity was found to be impaired in PBL obtained from patients 12h after IFN injection (Table II) , PBL obtained 12h post IFN injection were stimulated in vitro with the same IFN preparation that had been administred to the patients. In vitro exposure to IFN failed to augment NK cell activity both from responders and nonresponders ( Figure 2B Unstimulated cytotoxicity (%) Figure 2 In vitro effects of IFN on NK cell activity of blood lymphocytes obtained before (a) and 12 h (b) and 24 h (c) after IFN injection. Blood lymphocytes were incubated for 12 h alone or with 1,000 IU IFN ml 1, then washed and tested for cytotoxicity against K562 at an E:T of 10:1 in a 4 h 51Cr release assay.
(0) responder patients who showed augmented blood NK cell activity 24 h after IFN injection; (A) responders whose blood NK cell activity returned to base line levels 24 h post IFN injection; (-) nonresponders whose blood NK cell activity was not modified by IFN injection. Figure 2C ). An increase in NK cell activity was recorded for one PBL sample whose NK cell activity did not exceed base line levels 24 h after IFN injection. PBL from two nonresponsers were still unresponsive to IFN. Next, PBL from normal donors were incubated alone or with IFN either in the presence or absence of blood monocytes obtained from patients 24 h after IFN administration. In vitro treatment with IFN resulted in an augmentation of NK cell activity of control lymphocytes regardless of the presence of monocytes (Table VI) . These blood monocytes also (Pape et al., 1981) , in normal donors at 6 h (Karimiemi et al., 1980) , and in cancer patients at 12 h (Koren et al., 1983) or at 24 h (Golub et al., 1982a (Golub et al., , 1982b (Golub et al., 1982b) . In contrast, other investigators have reported that 2/3 patients develop nonadherent suppressor cells 12 h post IFN injection (Koren et al., 1983 (Ortaldo & Herberman, 1980; Targan & Dorey, 1980; Reynold et al., 1982 (Uchida & Micksche, 1981a , 1983b Uchida et al., 1982 Uchida et al., , 1984a (Ortaldo & Herberman, 1980; Targan & Dorey, 1980; Reynold et al., 1982 (Uchida & Micksche, 1981b) . Collectively, it seems likely that the initial depression of blood NK cell activity after IFN administration is unlikely to be due to a loss of NK cells in the blood but rather attributable to the unresponsiveness to IFN of pre-NK cells.
In conclusion, a significant but transient decline in blood NK cell activity has constantly been observed in cancer patients 12 h after IFN administration. The initial reduction of blood NK cell activity has been detected even after repeated injections of IFN (data not shown). The generation of suppressor monocytes capable of inhibiting IFNdependent development of functional NK cells appears to be involved in the initial depression of blood NK cell activity, although the mechanism by which suppressor monocytes appear in the peripheral blood shortly after IFN injection remains unclear. It could be postulated that a transition of pre-NK cells to active NK cells is regulated by monocytes.
